Low-Abundance Proteomics Reveal Pleiotrophin and Fibroblast Growth Factor-21 as Biomarkers of Metabolic Dysfunction-Associated Steatohepatitis.
Saved in:
| Title: | Low-Abundance Proteomics Reveal Pleiotrophin and Fibroblast Growth Factor-21 as Biomarkers of Metabolic Dysfunction-Associated Steatohepatitis. |
|---|---|
| Authors: | Milito, Melissa M.1,2 (AUTHOR), Mihajlovic, Milos1,2 (AUTHOR), Mallia, Alice3 (AUTHOR), Ghilardi, Stefania3,4 (AUTHOR), Tiribelli, Claudio1,5 (AUTHOR), Bonazza, Deborah4,6 (AUTHOR), Rosso, Natalia1 (AUTHOR), Palmisano, Silvia1,2,5,6 (AUTHOR), Banfi, Cristina3 (AUTHOR), Giraudi, Pablo J.1,4 (AUTHOR) pablo.giraudi@fegato.it |
| Source: | International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 22, p10943. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
